NCT05624398View on ClinicalTrials.gov

Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 7, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

May 1, 2025

Conditions
Glaucoma, Open-AngleCataract
Interventions
DEVICE

Vivity IOL

Cataract surgery with implantation of the Vivity IOL along with concurrent implantation of the Hydrus Microstent

Trial Locations (1)

72764

RECRUITING

Vold Vision P.L.L.C., Fayetteville

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Vold Vision P.L.L.C

OTHER

NCT05624398 - Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery | Biotech Hunter | Biotech Hunter